Novo Nordisk India partners with Emcure Pharma to distribute and market Poviztra (semaglutide) nationwide, expanding access ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible ...
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a ...
While weight loss drugs have helped people shed several pounds, some have also reported excess hair fall. A Delhi-based dermatologist recommended what you should do, including natural supplements, red ...
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
How effective is Wegovy at treating MASH? Novo Nordisk announced the results of the ESSENCE phase 3 trial at the American ...
Novo Nordisk A/S posted solid revenue and profit increases, with a resilient pipeline and strong dividend yield. Learn more ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...
Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...
Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.
Woman's World on MSN
Dr Blitz: TrumpRx Deal for Wegovy and Zepbound ‘Just What the Doctor Ordered'
After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...
A man who fainted in the Oval Office last week was a patient of a weight-loss drug company, according to reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results